Integral Molecular is recognized as a leader in membrane protein solutions, focusing on the isolation and characterization of complex membrane proteins, which are critical targets for drug development. The company employs advanced technologies such as the Membrane Proteome Array (MPA) platform, which features 6,000 human membrane proteins expressed on unfixed human cells. This platform is instrumental in antibody specificity profiling and identifying potential new therapeutic targets through functional assays. Integral Molecular also offers a range of services, including antibody discovery, epitope mapping, and protein engineering, aimed at enhancing the development of therapeutic monoclonal antibodies (mAbs) and other biotherapeutics.

In addition to its antibody discovery capabilities, Integral Molecular provides innovative tools for virology research, including Reporter Virus Particles (RVPs). These replication-incompetent pseudovirus particles facilitate safe and high-throughput assays for viral infectivity and neutralization, supporting vaccine and therapeutic development. The company’s commitment to advancing scientific research is further demonstrated through its therapeutic pipeline, which includes various preclinical assets available for licensing, targeting conditions such as cancer and autoimmune diseases. Integral Molecular's technologies and expertise are designed to address complex scientific challenges, making it a valuable partner for biotech and pharmaceutical companies.

United States

Integral Molecular is a research-driven biotechnology company specializing in antibodies, viruses, and membrane proteins. We develop technologies for solving big scientific challenges and advancing therapies against difficult-to-treat diseases. Our products, platforms, and services enable antibody discovery, biotherapeutic safety profiling, vaccine development, protein engineering, and more. Learn why top pharmaceutical and biotechnology companies trust Integral Molecular.

Instagram: IntegralMolecular

Integral Molecular

Company Details